Randomized, double-blinded, placebo-controlled trial of allogeneic cord blood T-regulatory cells for treatment of COVID-19 ARDS
Douglas E. Gladstone, Franco R. D’Alessio, Christopher Howard, Mi-Ae Lyu, Jason R. Mock, Kevin W. Gibbs, Darryl Abrams, Meixian Huang, Ke Zeng, James Herlihy, Sergio Castillo, Roland Bassett, Tara Sadeghi, Simrit Parmar, Christopher R. Flowers, Siddhartha Mukherjee, David Schoenfeld, Peter F. Thall, Arthur S. Slutsky
Topics & Concepts
ARDSMedicineCoronavirus disease 2019 (COVID-19)Randomized controlled trialPlaceboCord bloodDouble blinded2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)BetacoronavirusInternal medicineVirologyPathologyLungOutbreakAlternative medicineDiseaseInfectious disease (medical specialty)Long-Term Effects of COVID-19COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research